02.08.21 Business Of Biotech Introduces The Cell And Gene Series - New Episodes Out Now!
Business of Biotech and
Life Science Connect. As a member of the
Life Science Connect community you have access to content beyond our weekly newsletters, including our podcast series. Don’t forget to subscribe so that you never miss an episode!
On the latest episode of
Business of Biotech, Lineage Cell Therapeutics CEO, Brian Culley, explains how he kept the company s programs for OpRegen® (dry AMD with GA) and OPC1 (acute spinal cord injury) running on time despite the disruptions of a global pandemic.
Continuing our Cell & Gene Series,